Market Tracker

03/27 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

10.81
Delayed Data
As of 4:00pm ET
 +0.06 / +0.56%
Today’s Change
10.35
Today|||52-Week Range
38.50
-25.55%
Year-to-Date
Can This Pharma Stock Withstand the 'Trump Effect'?
Mar 25 / TheStreet.com - Paid Partner Content
Bill Ackman to Attend Ira Sohn Conference
Mar 23 / TheStreet.com - Paid Partner Content
Bill Ackman Finally Pukes: Beware of False Narratives
Mar 25 / GuruFocus News - Paid Partner Content
Troubled drug company pays CEO $63 million
Mar 23 / CNNMoney.com
Francis Chou Comments on Valeant
Mar 24 / GuruFocus News - Paid Partner Content
The 'Dogs' of Wall Street: Here's A Look at Some of the Worst Performing Stocks of Th...
Mar 23 / TheStreet.com - Paid Partner Content
Valeant: The End Of The Michael Pearson Era
Mar 23 / Investing Channel - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 23 / GuruFocus News - Paid Partner Content
Pernix: An Investor's Rationale to Staying Long
Mar 23 / GuruFocus News - Paid Partner Content
Democrats Target Trump SEC Pick Clayton Over Conflicts
Mar 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close10.75
Today’s open10.69
Day’s range10.66 - 10.94
Volume8,982,106
Average volume (3 months)18,019,715
Market cap$3.7B
Dividend yield--
Data as of 4:00pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-28.43%
Earnings growth (next 5 years)+3.95%
Revenue growth (last year)-7.39%
P/E ratioNM
Price/Sales0.52
Price/Book1.19

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co+0.22+0.43%
PTHNPatheon NV-0.07-0.27%
GLPGGalapagos NV+1.18+1.43%
CTLTCatalent Inc+0.42+1.50%
Data as of 4:02pm ET, 03/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.92
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts